TABLE 7.
Patient no. | IgG level (IU/ml) | Time after birth (wk) | MIC2a Rec-ELISA cutoff
|
SAG1 Rec-ELISA cutoff
|
||||||
---|---|---|---|---|---|---|---|---|---|---|
IgG1 | IgG2 | IgG3 | IgG4 | IgG1 | IgG2 | IgG3 | IgG4 | |||
T1 | 905 | 7 | 23.5 | 1.0 | 2.5 | 1.0 | 7.7 | 1.2 | 0.5 | 0.7 |
220 | 13 | 10.4 | 1.0 | 1.3 | 0.8 | 4.9 | 1.5 | 0.5 | 0.7 | |
T2 | 300 | 1 | 4.3 | 1.2 | 1.1 | 0.8 | 2.9 | 4.3 | 1.6 | 0.9 |
275 | 4 | 2.9 | 0.7 | 0.7 | 0.7 | 1.8 | 1.5 | 0.9 | 0.6 | |
T4 | 153 | 1 | 3.6 | 2.3 | 1.5 | 1.0 | 1.1 | 0.7 | 0.4 | 0.5 |
87 | 5 | 2.1 | 2.6 | 1.4 | 1.0 | 1.3 | 2.4 | 1.2 | 0.8 | |
T5 | 277 | 6 | 2.3 | 0.8 | 0.7 | 0.8 | 1.0 | 1.3 | 0.7 | 0.7 |
146 | 10 | 1.5 | 0.8 | 0.6 | 0.9 | 0.9 | 1.5 | 0.6 | 0.6 | |
T7 | 240 | 7 | 2.6 | 2.0 | 0.8 | 0.9 | 1.4 | 0.7 | 0.8 | 0.6 |
190 | 11 | 2.6 | 1.5 | 1.2 | 0.8 | 2.0 | 1.3 | 1.0 | 0.5 | |
T8 | 206 | 2 | 2.3 | 0.9 | 0.8 | 0.8 | 2.0 | 1.6 | 0.6 | 0.9 |
64 | 8 | 1.4 | 0.8 | 0.7 | 0.9 | 1.2 | 2.8 | 0.6 | 1.0 | |
T9 | 124 | 2 | 4.0 | 2.5 | 1.3 | 1.0 | 2.7 | 2.6 | 1.8 | 1.5 |
73 | 7 | 2.8 | 4.1 | 1.7 | 1.2 | 1.4 | 4.4 | 1.3 | 1.0 | |
T10 | 226 | 2 | 3.9 | 1.2 | 1.1 | 1.0 | 2.4 | 1.1 | 0.9 | 0.5 |
216 | 4 | 2.3 | 1.7 | 1.8 | 0.7 | 1.9 | 0.7 | 0.8 | 0.5 | |
T11 | 157 | 2 | 0.9 | 0.8 | 1.2 | 0.7 | 0.9 | 1.1 | 1.0 | 0.8 |
140 | 7 | 3.0 | 0.9 | 0.9 | 0.7 | 1.2 | 1.3 | 0.7 | 0.6 | |
T12 | 148 | 3 | 2.7 | 1.3 | 1.1 | 0.7 | 1.1 | 1.5 | 1.2 | 0.6 |
136 | 6 | 2.0 | 1.9 | 1.2 | 0.9 | 1.1 | 2.0 | 1.5 | 0.6 | |
T13 | 57 | 3 | 0.9 | 0.9 | 1.2 | 0.8 | 0.8 | 1.3 | 1.1 | 0.6 |
39 | 8 | 0.8 | 1.2 | 0.8 | 0.8 | 0.7 | 1.2 | 0.6 | 0.6 | |
T14 | 73 | 3 | 1.3 | 1.0 | 0.9 | 0.7 | 0.7 | 0.6 | 0.3 | 0.6 |
43 | 9 | 0.9 | 0.9 | 0.8 | 0.7 | 0.7 | 0.5 | 0.4 | 0.5 | |
T20 | 153 | 4 | 2.6 | 0.8 | 0.8 | 0.5 | 1.1 | 0.7 | 0.6 | 0.5 |
132 | 8 | 1.9 | 0.9 | 0.8 | 0.6 | 0.9 | 0.7 | 0.5 | 0.6 | |
T22 | 218 | 4 | 2.0 | 0.9 | 0.8 | 0.7 | 1.9 | 1.3 | 0.9 | 0.8 |
221 | 6 | 1.6 | 0.9 | 0.7 | 0.7 | 1.3 | 1.1 | 0.8 | 0.8 | |
T24 | 47 | 5 | 0.9 | 1.1 | 0.6 | 0.8 | 1.3 | 2.0 | 0.5 | 0.7 |
30 | 9 | 0.9 | 0.9 | 0.6 | 0.8 | 0.8 | 2.3 | 0.5 | 0.6 | |
T25 | 1,147 | 5 | 11.8 | 1.2 | 2.7 | 0.6 | 2.3 | 1.2 | 0.7 | 0.7 |
17 | 1.2 | 0.9 | 1.0 | 0.8 | 0.8 | 0.9 | 0.7 | 0.5 | ||
T29 | 292 | 6 | 25.2 | 1.3 | 5.8 | 0.7 | 2.9 | 0.8 | 1.1 | 0.6 |
300 | 10 | 14.6 | 1.1 | 3.8 | 0.5 | 2.8 | 0.7 | 0.8 | 0.5 | |
T30 | 39 | 3 | 2.2 | 0.9 | 1.3 | 0.7 | 0.8 | 1.0 | 0.4 | 0.5 |
28 | 6 | 9.7 | 1.0 | 8.3 | 0.7 | 0.8 | 0.9 | 0.3 | 0.5 | |
T34 | 59 | 8 | 3.3 | 0.7 | 0.9 | 0.9 | 1.1 | 1.1 | 0.4 | 0.8 |
176 | 13 | 6.9 | 0.9 | 3.1 | 1.0 | 1.0 | 1.6 | 0.6 | 0.6 | |
T35 | 91 | 4 | 1.3 | 0.9 | 0.8 | 0.5 | 1.3 | 1.7 | 1.0 | 0.4 |
67 | 8 | 0.9 | 0.8 | 0.4 | 0.4 | 1.0 | 0.9 | 0.5 | 0.5 |
Serial serum samples from infants with congenital toxoplasmosis were analyzed using IgG subtype Rec-ELISAs with GST fusion products. The values were calculated as the ratio of the test OD to the cutoff of the corresponding antigen. Italic type, OD > cutoff; bold type, serum sample pairs showing increasing IgG subtype reactivity with time.